Literature DB >> 22283662

Creating public awareness: state 2025 diabetes forecasts.

William R Rowley1, Clement Bezold.   

Abstract

The incidence and prevalence of diabetes (primarily type 2 diabetes) has risen sharply since 1990. It is projected to increase another 64% between 2010 and 2025, affecting 53.1 million people and resulting in medical and societal costs of a half trillion dollars a year. We know how to prevent many cases of diabetes and how to treat it effectively. Early appropriate treatment makes a significant difference in preventing major complications and reducing premature death, but it does not cure the disease. Early detection of prediabetes, in conjunction with lifestyle changes, can reduce the number of people with diabetes. A dramatic reduction in diabetes prevalence over time will require significant lifestyle changes on the part of society as a whole. The purpose of this study is to increase public awareness of the severity of regional diabetes trends by providing detailed forecasts for all states and several metropolitan areas for 2010, 2015, and 2025. A model was created to utilize the latest national diabetes and population data and projections, and to transform these into state and metropolitan area forecasts for the whole population and major subgroups. These forecasts were then summarized in easy-to-understand briefing papers for each state and selected metro areas, which are provided online for easy public access. This research is important because little data exist that project the future prevalence and potential costs of diabetes at the state and metro area level. With this data, key stakeholders can make informed decisions concerning diabetes, its impact on their communities, and resource allocation.

Entities:  

Mesh:

Year:  2012        PMID: 22283662     DOI: 10.1089/pop.2011.0053

Source DB:  PubMed          Journal:  Popul Health Manag        ISSN: 1942-7891            Impact factor:   2.459


  19 in total

Review 1.  3D-Models of Insulin-Producing β-Cells: from Primary Islet Cells to Stem Cell-Derived Islets.

Authors:  Diana Ribeiro; Alexander J Kvist; Pernilla Wittung-Stafshede; Ryan Hicks; Anna Forslöw
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

2.  Leveling-off of declining trend of cardiovascular disease-related mortality in the USA: the challenge to rein in obesity and diabetes epidemic.

Authors:  Aisha Zia; Hafiz U Siddiqui; Hafsa Mohiuddin; Sajjad Gul
Journal:  Cardiovasc Endocrinol Metab       Date:  2018-05-16

Review 3.  Microvascular remodeling and wound healing: a role for pericytes.

Authors:  Brian M Dulmovits; Ira M Herman
Journal:  Int J Biochem Cell Biol       Date:  2012-06-28       Impact factor: 5.085

Review 4.  Economic Impact of Diabetes in Japan.

Authors:  Tatsuhiko Urakami; Remi Kuwabara; Kei Yoshida
Journal:  Curr Diab Rep       Date:  2019-01-16       Impact factor: 4.810

5.  Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes.

Authors:  Alan Penman; Heather Hancock; Evangelia Papavasileiou; Maurice James; Omolola Idowu; Daniel M Riche; Marlene Fernandez; Stacey Brauner; Sataria O Smith; Suzanne Hoadley; Cole Richardson; Vanessa Vazquez; Cheryl Chi; Christopher Andreoli; Deeba Husain; Ching J Chen; Lucia Sobrin
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

6.  Developing a Culturally Informed Survey Instrument to Assess Biomedical Research Participation Among Latinos on the U.S.-Mexico Border.

Authors:  Sarah D Hohl; Rachel Ceballos; Mary Alice Scott; Beti Thompson
Journal:  Qual Health Res       Date:  2018-10-10

7.  Trends in Medical Expenditures by Race/Ethnicity in Adults with Type 2 Diabetes 2002-2011.

Authors:  Aprill Z Dawson; Kinfe G Bishu; Rebekah J Walker; Leonard E Egede
Journal:  J Natl Med Assoc       Date:  2020-08-06       Impact factor: 1.798

Review 8.  Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options.

Authors:  Susan Cornell
Journal:  Ther Clin Risk Manag       Date:  2015-04-16       Impact factor: 2.423

9.  Assessment of Antidiabetic Activity of the Shikonin by Allosteric Inhibition of Protein-Tyrosine Phosphatase 1B (PTP1B) Using State of Art: An In Silico and In Vitro Tactics.

Authors:  Mohd Saeed; Ambreen Shoaib; Munazzah Tasleem; Nadiyah M Alabdallah; Md Jahoor Alam; Zeina El Asmar; Qazi Mohammad Sajid Jamal; Fevzi Bardakci; Saad S Alqahtani; Irfan Ahmad Ansari; Riadh Badraoui
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

10.  Development and Evaluation of a Computer-Based, Self-Management Tool for People Recently Diagnosed with Type 2 Diabetes.

Authors:  Alison O Booth; Carole Lowis; Steven J Hunter; Moira Dean; Chris R Cardwell; Michelle C McKinley
Journal:  J Diabetes Res       Date:  2016-06-30       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.